4//SEC Filing
CONKLING WILLIAM 4
Accession 0001437749-24-004379
CIK 0000922247other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:41 PM ET
Size
4.9 KB
Accession
0001437749-24-004379
Insider Transaction Report
Form 4
CONKLING WILLIAM
Director
Transactions
- Award
Common Stock
2024-02-13+6,330→ 16,245 total
Footnotes (1)
- [F1]Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the fourth quarter of 2023. The number of shares received in lieu of cash was calculated based on the closing price of $1.58 per share of common stock on February 13, 2024.
Documents
Issuer
Cyclo Therapeutics, Inc.
CIK 0000922247
Entity typeother
Related Parties
1- filerCIK 0001852018
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:41 PM ET
- Size
- 4.9 KB